• A Study for Those with Diabetic Macular Edema--The BOULEVARD Study

    Official Title A PHASE 3, DOUBLE-MASKED, RANDOMIZED STUDY OF THE EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT INJECTION IN PATIENTS WITH MODERATELY SEVERE TO SEVERE NONPROLIFERATIVE DIABETIC RETINOPATHY

    Purpose

    The purpose of this 28-week study to investigate the effects and safety of a medication in participants with Center Involving Diabetic Macular Edema (CI-DME). .

    Could this study be right for you?

    • 18 years and older
    • Macular edema associated with diabetic retinopathy (DR)
    • Diagnosis of diabetes mellitus (DM)

    Age Range

    18 and up